JPRN-UMIN000030596已完成未知
Effect of canagliflozin for postprandial glucose control - Effect of canagliflozin for postprandial glucose control
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Type 1 diabetes,2)Patients whose blood glucose level is less than 100 mg /dL on under insulin or sulfonylurea treatment, 3)Patients with postvoid residual urine of benign prostatic hyperplasia and neurogenic bladder,4)eGFR<30mL/min/1.73m2,5)Women who were pregnant, possibly pregnant, or were breast-feeding,6)Genital infection or urinary tract infection,7)Being treated diuretics,8)Insulin-dependent type 2 diabetes,9)Other patients who were considered to be ineligible for the study by the attending doctor
研究者
相似试验
已完成
不适用
Effects of canagliflozin on the glycemic control and plasma GLP-1 levels.Type 2 diabetes mellitusJPRN-UMIN000018345akakinen clinic45
已完成
1 期
A Study to Evaluate the Effect of JNJ-28431754 (Canagliflozin) on Post-Meal Glucose in Patients With Type 2 Diabetes MellitusDiabetes Mellitus, Type 2NCT01381887Johnson & Johnson Pharmaceutical Research & Development, L.L.C.37
招募中
不适用
Effect of Canagliflozin in Non-diabetic overweight and obesity Patients with albuminuria: A Randomized, Double-blind, Placebo-controlled TrialEffect of Canagliflozin in Non-diabetic overweight and obesity Patients.Canagliflozin and Non-diabetic overweight and obesity PatientsTCTR20190203003Rachadaphiseksompot Endorsement Fund80
尚未招募
不适用
Canagliflozin in non diabetic proteinuric diseaseCTRI/2020/09/027679COMMAND HOSPITAL AIR FORCE BANGALORE
已完成
1 期
A Study of 28431754 (Canagliflozin) on Gastrointestinal Glucose Absorption and Metabolism in Healthy VolunteersHealthyNCT01173549Johnson & Johnson Pharmaceutical Research & Development, L.L.C.26